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introduction: Acute mesenteric ischemia is a surgical emergency that entails complex, 
multi-modal management, but its epidemiology and outcomes remain poorly defined. 
The aim of this study was to perform a population analysis of the contemporary inci-
dence and outcomes of mesenteric ischemia.
Methods: This was a retrospective analysis of acute mesenteric ischemia in the state of 
Maryland during 2009–2013 using a comprehensive statewide hospital admission data-
base. Demographics, illness severity, comorbidities, and outcomes were studied. The 
primary outcome was inpatient mortality. Survivors and non-survivors were compared 
using univariate analyses, and multivariable logistic regression analysis was performed 
to evaluate risk factors for mortality.
results: During the 5-year study period, there were 3,157,499 adult hospital admis-
sions in Maryland. A total of 2,255 patients (0.07%) had acute mesenteric ischemia, 
yielding an annual admission rate of 10/100,000. Increasing age, hypercoagulability, 
cardiac dysrhythmia, renal insufficiency, increasing illness severity, and tertiary hospital 
admission were associated with development of mesenteric ischemia. Inpatient mortality 
was high (24%). After multivariate analysis, independent risk factors for death were age 
>65  years, critical illness severity, mechanical ventilation, tertiary hospital admission, 
hypercoagulability, renal insufficiency, and dysrhythmia.
conclusion: Acute mesenteric ischemia occurs in approximately 1/1,000 admissions in 
Maryland. Patients with mesenteric ischemia have significant illness severity, substantial 
rates of organ dysfunction, and high mortality. Patients with chronic comorbidities and 
acute organ dysfunction are at increased risk of death, and recognition of these risk fac-
tors may enable prevention or earlier control of mesenteric ischemia in high-risk patients.
Keywords: acute mesenteric ischemia, epidemiology, surgical critical care, emergency surgery
Abbreviations: APR, all patient refined; HSCRC, health services cost review commission; ICD-9, International Classification 
of Diseases, Ninth Revision; ROM, risk of mortality; SOI, severity of illness.
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inTrODUcTiOn
Acute mesenteric ischemia is the final common pathway of a 
range of conditions that lead to critical malperfusion of the small 
and/or large intestine (1–3). Mesenteric ischemia can occur from 
primary mesenteric vascular insufficiency from venous throm-
bosis, arterial embolism, or thrombosis, or secondarily as a com-
plication of low inflow (non-obstructive mesenteric ischemia) or 
aortic dissection (1–5). Regardless of its cause, acute mesenteric 
ischemia is a surgical emergency that entails complex general and 
vascular surgical management and is associated with significant 
morbidity and mortality (2, 5–8).
Mesenteric ischemia is the most frequent cause of peritonitis 
among critically ill patients and is a common indication for 
emergency bowel resection (9, 10). Among the elderly and 
critically ill, it is an independent risk factor for mortality (9, 11). 
Early mortality rates from mesenteric ischemia range from 20 to 
80%, with survivors remaining at risk for significant long-term 
morbidity and late death (5–7, 12). However, the incidence and 
outcomes of acute mesenteric ischemia are poorly defined, in part 
due to limitations of institutional- and population-based studies 
to date (5–7, 12, 13). The purpose of this study was to evaluate the 
modern incidence and outcomes of acute mesenteric ischemia in 
a statewide database analysis.
MaTerials anD MeThODs
A retrospective analysis of mesenteric ischemia in the state of 
Maryland from 2009 to 2013 using the Health Services Cost 
Review Commission (HSCRC) database was performed. The 
HSCRC regulates hospital payment rates in Maryland and 
maintains a de-identified inpatient dataset that contains medi-
cal and billing data for all inpatient admissions to the state’s 51 
hospitals (46 acute care, 3 psychiatric, and 2 specialty facilities) 
(14, 15). Data elements include demographics, hospital disposi-
tion, International Classification of Diseases (ICD-9) diagnosis 
and procedure codes, and All Patient Refined (APR) Diagnosis-
Related Groups. Illness severity is categorized by the APR-severity 
of illness (SOI), an ordinal scale of minor, moderate, major, or 
extreme, reflecting the degrees of acute physiologic decompen-
sation and organ dysfunction. Similarly, the Diagnosis-Related 
Group adjusted risk of death is classified by the APR-risk of mor-
tality (ROM) using the same categorization (16, 17). The dataset 
was used under a Research Data Use Agreement approved by the 
HSCRC board, and the study was approved by the University of 
Maryland, Baltimore Institutional Review Board with a waiver 
for patient consent given the retrospective design and use of a 
de-identified dataset.
Patients at least 18 years old were included for analysis. Acute 
mesenteric ischemia was operationally defined as an ICD-9 
code for acute intestinal ischemia (557.0 or 557.9) plus the need 
for abdominal surgery during the same admission (Table S1 in 
Supplementary Material) (18). The latter criteria were included 
to ensure clinically significant, and confirmed episodes of the 
disease were captured. Although potential readmissions could 
not be identified within the dataset, all admissions were assumed 
to be index events based on the natural history of mesenteric 
ischemia. Analyzed data included patient demographics, comor-
bidities, management, complications, and disposition. Statewide 
population data were obtained from the Maryland State Data 
Center (19), using census and intercensal estimates to determine 
the population at risk. Based on previous analysis of emergency 
general surgery in Maryland and resources available for acute 
surgical care, the state’s two Level I trauma centers were defined 
as tertiary referral centers for this study (16).
The primary outcome was inpatient mortality. Survivors and 
non-survivors were compared by chi-squared, Satterthwaite t, or 
Wilcoxon tests as appropriate. Variables associated with mortal-
ity on univariate analysis were assessed by multivariable logistic 
regression using automatic step-wise selection, and retained 
for a multivariable P < 0.01. For multivariate analyses, SOI was 
dichotomized as extreme or non-extreme, and bowel resection 
was categorized as small intestine or colon resection alone, or 
both, and compared to no bowel resection. Model calibration was 
assessed using the Hosmer–Lemeshow goodness of fit test. Data 
were analyzed using SAS 9.3 software (SAS Institute).
resUlTs
During the 5-year study period, there were 3,157,499 adults 
admitted to Maryland hospitals. A total of 2,255 adults had acute 
mesenteric ischemia as defined by ICD-9 diagnosis and need 
for abdominal surgery, representing 0.07% of inpatient admis-
sions. Based on an average state population of 5.8 million during 
2009–2013, the annual admission rate among Maryland adults 
was 10 per 100,000.
Patients with acute mesenteric ischemia were generally 
elderly, white, and female (Table 1). The majority of admissions 
(90%) were classified as urgent or emergent, with 81% of patients 
presenting via the emergency department. Only 17% of patients 
were admitted to tertiary hospitals. Compared to patients 
without mesenteric ischemia, the study group was older, more 
frequently Caucasian, and more likely to be admitted emergently 
and to a tertiary hospital. Specific mechanisms of ischemia 
were not discernable from the database, but among potential 
etiologies and contributing conditions, 198 (9%) patients had 
a hypercoagulable state, 37 (2%) had an arterial embolic event, 
and 12 (1%) had arterial dissection. Representing significant 
acute physiologic dysfunction and risk of death, 68% of patients 
with mesenteric ischemia had extreme APR-SOI, and 59% had 
extreme APR-ROM.
Chronic comorbidities and acute organ dysfunction were 
common among the study group (Table  2). On univariate 
analyses, hypercoaguability, cardiac dysrhythmia, chronic kidney 
disease, and increasing APR-SOI were associated with mesenteric 
ischemia; diabetes and hypertension were less common among 
patients with mesenteric ischemia. Heterogeneity within the 
study group limited multivariable analysis of factors associated 
with development of mesenteric ischemia. However, under 
multiple stratified models, tertiary hospital admission, extreme 
APR-SOI, hypercoagulability, and arterial embolic events were 
consistent independent risk factors for mesenteric ischemia.
TaBle 2 | comorbidities and illness severity.




P survivors non-survivors P
Number 3,155,244 2,255 1,825 577
Condition, n (%)
Diabetes mellitus 786,591 (25%) 350 (16%) <0.0001 279 (16%) 71 (13%) <0.05
Hypertension 1,053,797 (33%) 607 (27%) <0.0001 519 (30%) 88 (16%) <0.0001
Hypercoagulable state 47,689 (2%) 198 (9%) <0.0001 87 (5%) 111 (20%) <0.0001
Ischemic heart disease 634,570 (20%) 405 (18%) 0.01 275 (16%) 130 (24%) <0.0001
Cardiac dysrhythmia 625,989 (20%) 618 (27%) <0.0001 423 (25%) 195 (35%) <0.0001
PAD 130,649 (4%) 91 (4%) 0.80 65 (4%) 26 (5%) 0.35
Chronic comorbidities, n (%)
COPD 345,330 (11%) 264 (12%) 0.25 185 (11%) 79 (14%) 0.03
Congestive heart failure 363,843 (12%) 259 (11%) 0.95 177 (10%) 82 (15%) 0.004
Chronic kidney disease 507,982 (16%) 861 (38%) <0.0001 519 (30%) 342 (62%) <0.0001
Severity of illness, n (%) <0.0001 <0.0001
Minor 562,464 (18%) 5 (< 1%) 5 (< 1%) 0
Moderate 1,208,321 (38%) 181 (8%) 181 (11%) 0
Major 1,032,943 (33%) 540 (24%) 522 (31%) 18 (3%)
Extreme 351,516 (11%) 1529 (68%) 996 (58%) 533 (97%)
Risk of mortality, n (%) <0.0001 <0.0001
Minor 1,526,896 (48%) 81 (3%) 81 (5%) 0
Moderate 843,060 (27%) 245 (10%) 245 (14%) 0
Major 550,003 (17%) 589 (25%) 550 (32%) 39 (7%)
Extreme 235,285 (7%) 1,340 (57%) 828 (49%) 512 (93%)
PAD, peripheral arterial disease; COPD, chronic obstructive pulmonary disease.
TaBle 1 | Patient demographics.




P survivors non-survivors P
Number 3,155,244 2,255 1,704 551
Demographics, n (%)a
Age, years ± SD 57 ± 20 67 ± 16 0.0001 66 ± 17 71 ± 15 <0.0001
Age >65 years 1,204,123 (38%) 1,321 (59%) 0.0001 939 (55%) 382 (69%) <0.0001
Female 1,870,001 (59%) 1,321 (59%) 0.51 1,010 (59%) 311 (56%) 0.24
White 1,892,553 (60%) 1,617 (72%) 0.0001 1,231 (72%) 386 (70%) 0.32
Medicare insurance 1,358,289 (43%) 1,379 (61%) 0.0001 988 (58%) 391 (71%)  <0.0001
Admission, n (%)
Emergent 2,280,960 (72%) 2,027 (90%) 0.0001 1,534 (90%) 493 (89%) 0.71
ED presentation 1,997,807 (63%) 1,824 (81%) 0.0001 1,402 (82%) 422 (77%) 0.003
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Small intestine involvement was the most common form of 
mesenteric ischemia based on procedure codes for bowel resec-
tions (38%; Table  3). Colonic involvement occurred in 27%, 
while 21% had both small and large bowel ischemia. However, 
172 (7%) patients had no bowel resection, making their distribu-
tion unclear. Vascular intervention in this cohort was infrequent 
and was more common among non-survivors (7 versus 4%, 
P <  0.005). Patients who died required more intensive critical 
care management, including higher rates of mechanical ventila-
tion, dialysis, and blood product transfusion.
The overall mortality in the study group was 24%. On univariate 
analyses, increasing age, admission to a tertiary hospital, hyper-
coagulability, cardiac disease, renal insufficiency, illness severity, 
mechanical ventilation, dialysis, and transfusions were associated 
with mortality (Tables 1–3). Patients who died were more likely 
to require a combination of small and large bowel resection, or to 
undergo no resection at all. Age, illness severity, tertiary hospital 
admission, hypercoagulability, renal insufficiency, dysrhythmia, 
and respiratory failure were independent risk factors for mortal-
ity (Table 4). Compared to no bowel resection, resection of the 
small and/or large bowel was associated with similarly reduced 
mortality. Among survivors, 58% were discharged to home, 24% 
to a nursing facility, 9% to a rehabilitation center, and 6% to 
another acute hospital.
DiscUssiOn
Admission for mesenteric ischemia occurs in approximately 
10/100,000 adults and in 1/1,000 inpatient admissions in 
Maryland. Though relatively uncommon, the disease complexity, 
TaBle 4 | Multivariable analysis of risk factors for mortality.
Variable Odds ratio (95% ci) P
Age > 65 years 1.8 (1.4–2.3) <0.0001
Extreme severity of illness 2.8 (1.5–5.3) <0.0001
Tertiary hospital admission 1.9 (1.4–2.5) <0.0001
Hypercoagulability 2.6 (1.8–3.7) <0.0001
Chronic kidney disease 1.8 (1.4–2.3) <0.0001
Cardiac dysrhythmia 1.5 (1.1–1.9) 0.003
Mechanical ventilation 2.9 (2.3–3.8) <0.0001
Bowel resection
None (reference) 1.0
Small intestine 0.13 (0.09–0.21) <0.0001
Large intestine 0.15 (0.10–0.23) <0.0001
Small + large intestine 0.19 (0.12–0.30) <0.0001
Hosmer–Lemeshow goodness of fit: χ2 = 8.9, P = 0.35.
c-Statistic = 0.85.
TaBle 3 | Patient management.
characteristic Mesenteric ischemia survivors non-survivors P
Number 2,255 1,704 551
Gastrointestinal surgery, n (%)
No bowel resected 172 (7%) 70 (4%) 102 (19%) <0.0001
Small bowel resection 920 (38%) 781 (46%) 139 (25%) 0.005
Large bowel resection 651 (27%) 518 (30%) 133 (24%) <0.0001
Small and large bowel resections 512 (21%) 335 (20%) 177 (32%) <0.0001
Vascular intervention, n (%) 99 (4%) 62 (4%) 37 (7%) 0.002
Open 11 (< 1%) 7 (< 1%) 4 (1%) 0.48
Endovascular 88 (4%) 55 (3%) 33 (6%) 0.004
Critical care, n (%)
Mechanical ventilation 897 (37%) 494 (29%) 403 (73%) <0.0001
Parenteral nutrition 774 (32%) 594 (35%) 180 (33%) 0.35
Dialysis 181 (8%) 90 (5%) 91 (17%) <0.0001
Transfusion 1,031 (43%) 711 (42%) 320 (58%) <0.0001
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illness severity, frequent requirement for operative intervention, 
and high associated mortality make it a significant burden on 
health care resources in Maryland. Findings in this study indicate 
that illness severity is the leading risk factor for mortality. The 
infrequency of traditional mechanisms of disease and low rate 
of vascular interventions suggest a high prevalence of low-flow 
mesenteric ischemia or hemodynamically occult mesenteric 
vascular disease. Definition of additional risk factors, including 
age, hypercoagulability, and comorbidities may help identify 
high-risk subgroups that may benefit physiologic optimization 
or possible intervention to prevent onset of mesenteric ischemia.
Few studies have assessed the epidemiology of mesenteric 
ischemia. In an analysis of the National Inpatient Sample by 
Beaulieu et al., 0.06% of patients had mesenteric ischemia (13). 
Based on extensive autopsy studies in Malmö, Sweden, Acosta 
estimated an incidence of 13/100,000 (3). While limitations of 
these studies may hinder their applicability and differences in 
methodology limit direct comparison between studies, these 
findings are similar to the 0.07% inpatient rate and statewide 
admission rate of 10/100,000 in the current study. Given the detail 
of this analysis and correlation with state population data, the 
study provides critical further insight into the epidemiology of 
mesenteric ischemia.
The complexity and heterogeneous pathogenesis of mesen-
teric ischemia has so far made it difficult to define specific risk 
factors for disease onset and mortality (2, 5, 20). This analysis 
demonstrated that advanced age, admission to a tertiary hos-
pital, critical illness, hypercoagulability, chronic kidney disease, 
and dysrhythmia are associated with developing and dying 
from mesenteric ischemia. We were unable to evaluate specific 
etiologies of acute mesenteric ischemia in this dataset, but con-
ditions traditionally associated with specific mechanisms such 
as embolism or hypercoagulability were relatively infrequent, 
suggesting a high prevalence of low-flow or hemodynamically 
occult mesenteric ischemia.
Consistent with a predominance of low-flow ischemia, illness 
severity and critical illness, as reflected by APR-SOI and need 
for mechanical ventilation, were the strongest risk factors for 
acute mesenteric ischemia onset and mortality. In the setting of 
critical illness, this could be attributable to true non-obstructive 
mesenteric ischemia or malperfusion superimposed upon 
otherwise occult chronic mesenteric vascular disease. Further 
study of risk factors specific to acute mesenteric ischemia in 
critically ill patients is warranted. Identification of high-risk 
patients, perhaps based on the presence of other risk factors or 
imaging characteristics, could help identify patients at increased 
risk for mesenteric ischemia and who may benefit from aggres-
sive physiologic optimization and/or treatment of underlying 
vascular lesions.
Additional risk factors identified in this study, such as 
hypercoagulability and dysrhythmia, are consistent with tradi-
tional mechanisms of vascular occlusive mesenteric ischemia. 
Unfortunately, the nature and specific contribution of each are 
unclear. For example, these data do not indicate if hyperco-
agulability was potentially associated with mesenteric ischemia 
from venous versus arterial thrombosis. Similarly, dysrhythmia 
could contribute to vascular occlusive mesenteric ischemia from 
cardiogenic embolization or non-occlusive ischemia from low 
cardiac output.
Vascular interventions were infrequent in this study, which 
is consistent with a high prevalence of systemic malperfusion 
in the setting of critical illness. In this setting, optimal therapy 
entails optimization of systemic perfusion and resection of 
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non-viable bowel, with limited role for vascular intervention. 
However, patients with hemodynamically occult chronic mesen-
teric arterial stenosis may be more susceptible to develop acute 
ischemia in the setting of systemic malperfusion. Further study 
is required to determine if such high risk patients would benefit 
from prophylactic intervention in the setting of critical illness. 
Under specific circumstances, such as embolic events with sal-
vageable intestine, there is a clear role for vascular intervention, 
but this study indicates that these events are relatively infrequent.
Intuitively, bowel resection has a protective effect on mortality 
for patients with acute mesenteric ischemia. Patients in this study 
not undergoing bowel resection had significantly higher mortal-
ity than those who did. Presumably, patients who did not undergo 
bowel resection either had marginal bowel that was either viable or 
not appropriately resected, or non-survivable extensive involve-
ment. While the distribution and extent of bowel involvement 
likely affects patient outcomes, different patterns of bowel resec-
tion were not independently associated with mortality. However, 
we were unable to account for the potential contribution of 
absolute length of resected bowel, number of resected segments, 
or final gastrointestinal continuity, which may affect short and 
long-term outcomes.
This study demonstrated a large burden of mesenteric ischemia 
managed at non-tertiary hospitals. Despite overall high mortality 
and disease complexity, the majority of patients were cared for at 
community facilities rather than transferred to tertiary centers. 
Further, tertiary hospitals had higher incidence and worse mor-
tality even after adjusting for patient characteristics and illness 
severity. Given the growing regionalization of emergency general 
surgical care (21, 22), this finding warrants further exploration. 
The inter-facility transfer rate was, in the study, low but could 
represent a subgroup with disproportionately high mortality that 
could confound mortality at tertiary centers. Further, given the 
non-specific categorization of illness severity by the APR-SOI 
scale, the database may have failed to capture critical granular 
data that may further explain differences in risk and outcomes 
between community and tertiary hospitals, particularly for high-
acuity critically ill patients who may be particularly susceptible to 
non-occlusive mesenteric ischemia.
The 24% mortality rate in this study is at the low end of the 
20–80% short-term mortality rates reported in institutional series 
(2, 5–7, 12). Beaulieu et al. reported 36% mortality for mesenteric 
ischemia in the National Inpatient Sample but that analysis was 
limited to patients undergoing revascularization for mesenteric 
ischemia (13). As such, this comprehensive, population-based 
analysis may serve as a benchmark for early outcomes after mes-
enteric ischemia. While long-term outcomes data were not avail-
able in this dataset, the relatively high rate of home discharges 
among survivors suggests that meaningful recovery is achievable 
for many patients.
This study has important limitations. While the HSCRC data-
base contains detailed patient level clinical data, the reliability of 
the results are limited by the use of an administrative database 
that was not designed for nuanced clinical analyses and depends 
on the quality of on-site data abstraction. Further, it lacks granu-
lar and time course data to give detailed insight into clinically 
important concerns such as the time between disease onset and 
intervention. While the admission rate in this study provides an 
approximation of incidence, determination of the true rate of mes-
enteric ischemia was confounded by two methodological factors. 
First, by using a de-identified database, we were unable to account 
for patient readmissions. Second, while operationally defining 
acute mesenteric ischemia by ICD-9 coding plus abdominal 
surgery may have improved the specificity of our study, we may 
have missed patients that died prior to hospitalization or were 
not surgical candidates. Finally, as a purely retrospective analysis, 
the ability to make definitive conclusions about the associations 
noted in the data is inherently limited.
cOnclUsiOn
This study found a significant rate of mesenteric ischemia in a large, 
comprehensive statewide database and population analysis. These 
results demonstrated that critical illness is a leading risk factor for 
mesenteric ischemia onset and mortality. In our analysis, most 
patients are treated by bowel resection without vascular inter-
vention, which suggests a significant burden of  non-obstructive 
mesenteric ischemia or hemodynamically occult mesenteric 
vascular disease that is unmasked in the setting of critical illness. 
Additional risk factors may help identify patients at risk for this 
disease process. Mortality from mesenteric ischemia is high, but 
is significantly lower than suggested by prior studies that focused 
on acute vascular occlusive mesenteric ischemia. Further study 
is warranted to better define the interaction between patient and 
systematic risk factors.
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